FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2145411175> ?p ?o ?g. }

• W2145411175 abstract "Background Reduced ankle dorsiflexion range of motion, or ankle equinus, is a common and disabling problem for patients with neuromuscular disease. Clinicians devote considerable time and resources implementing interventions to correct this problem although few of these interventions have been subject to rigorous empirical investigation. Objectives To assess the effect of interventions to reduce or resolve ankle equinus in people with neuromuscular disease. Search methods We searched the Cochrane Neuromuscular Disease Group Trials Specialized Register (August 2009), Cochrane Central Register of Controlled Trials (The Cochrane Library Issue 3, 2009), MEDLINE (1966 to August 2009), EMBASE (1980 to August 2009), CINAHL 1982 to August 2009), AMED (1985 to August 2009) and The Physiotherapy Evidence Database (PEDro) (1929 to August 2009). We searched the reference lists of identified articles and also contacted known experts in the field to identify additional or unpublished data. Selection criteria Randomised controlled trials evaluating interventions for increasing ankle dorsiflexion range of motion in neuromuscular disease. Outcomes included ankle dorsiflexion range of motion, functional improvement, foot alignment, foot and ankle muscle strength, health‐related quality of life, satisfaction with the intervention and adverse events. Data collection and analysis Two authors independently selected papers, assessed trial quality and extracted data. Main results Four studies involving 149 participants met inclusion criteria for this review. Two studies assessed the effect of night splinting in a total of 26 children and adults with Charcot‐Marie‐Tooth disease type 1A. There were no statistically or clinically significant differences between wearing a night splint and not wearing a night splint. One study assessed the efficacy of prednisone treatment in 103 boys with Duchenne muscular dystrophy. While a daily dose of prednisone at 0.75 mg/kg/day resulted in significant improvements in some strength and function parameters compared with placebo, there was no significant difference in ankle range of motion between groups. Increasing the prednisone dose to 1.5 mg/kg/day had no significant effect on ankle range of motion. One study evaluated early surgery in 20 young boys with Duchenne muscular dystrophy. Surgery resulted in increased ankle dorsiflexion range at 12 months but functional outcomes favoured the control group. By 24 months, many boys in the surgical group experienced a relapse of achilles tendon contractures. Authors' conclusions There is no evidence of significant benefit from any intervention for increasing ankle range of motion in Charcot‐Marie‐Tooth disease type 1A or Duchenne muscular dystrophy. Further research is required." @default.
• W2145411175 created "2016-06-24" @default.
• W2145411175 creator A5008514328 @default.
• W2145411175 creator A5015504090 @default.
• W2145411175 creator A5069396815 @default.
• W2145411175 creator A5081481886 @default.
• W2145411175 date "2010-02-17" @default.
• W2145411175 modified "2023-09-26" @default.
• W2145411175 title "Interventions for increasing ankle range of motion in patients with neuromuscular disease" @default.
• W2145411175 cites W1598602811 @default.
• W2145411175 cites W1806294472 @default.
• W2145411175 cites W1963597100 @default.
• W2145411175 cites W1982385357 @default.
• W2145411175 cites W1982659220 @default.
• W2145411175 cites W1988308528 @default.
• W2145411175 cites W1991240629 @default.
• W2145411175 cites W1999113624 @default.
• W2145411175 cites W2000575070 @default.
• W2145411175 cites W2010196547 @default.
• W2145411175 cites W2016615191 @default.
• W2145411175 cites W2026637706 @default.
• W2145411175 cites W2027019453 @default.
• W2145411175 cites W2031978684 @default.
• W2145411175 cites W2033921590 @default.
• W2145411175 cites W2037023946 @default.
• W2145411175 cites W2042646718 @default.
• W2145411175 cites W2046966094 @default.
• W2145411175 cites W2063365809 @default.
• W2145411175 cites W2063816661 @default.
• W2145411175 cites W2064216106 @default.
• W2145411175 cites W2065826225 @default.
• W2145411175 cites W2072973612 @default.
• W2145411175 cites W2073481346 @default.
• W2145411175 cites W2075207246 @default.
• W2145411175 cites W2076658502 @default.
• W2145411175 cites W2089305683 @default.
• W2145411175 cites W2097412203 @default.
• W2145411175 cites W2097764500 @default.
• W2145411175 cites W2098925350 @default.
• W2145411175 cites W2109280530 @default.
• W2145411175 cites W2109889650 @default.
• W2145411175 cites W2111677419 @default.
• W2145411175 cites W2118991239 @default.
• W2145411175 cites W2121765071 @default.
• W2145411175 cites W2134552162 @default.
• W2145411175 cites W2149754919 @default.
• W2145411175 cites W2152099046 @default.
• W2145411175 cites W2153189193 @default.
• W2145411175 cites W2158136973 @default.
• W2145411175 cites W2161966076 @default.
• W2145411175 cites W2162582222 @default.
• W2145411175 cites W2170756299 @default.
• W2145411175 cites W2220448176 @default.
• W2145411175 cites W2327656791 @default.
• W2145411175 cites W2388373414 @default.
• W2145411175 cites W4238163958 @default.
• W2145411175 doi "https://doi.org/10.1002/14651858.cd006973.pub2" @default.
• W2145411175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20166090" @default.
• W2145411175 hasPublicationYear "2010" @default.
• W2145411175 type Work @default.
• W2145411175 sameAs 2145411175 @default.
• W2145411175 citedByCount "23" @default.
• W2145411175 countsByYear W21454111752012 @default.
• W2145411175 countsByYear W21454111752013 @default.
• W2145411175 countsByYear W21454111752014 @default.
• W2145411175 countsByYear W21454111752015 @default.
• W2145411175 countsByYear W21454111752016 @default.
• W2145411175 countsByYear W21454111752019 @default.
• W2145411175 countsByYear W21454111752022 @default.
• W2145411175 countsByYear W21454111752023 @default.
• W2145411175 crossrefType "journal-article" @default.
• W2145411175 hasAuthorship W2145411175A5008514328 @default.
• W2145411175 hasAuthorship W2145411175A5015504090 @default.
• W2145411175 hasAuthorship W2145411175A5069396815 @default.
• W2145411175 hasAuthorship W2145411175A5081481886 @default.
• W2145411175 hasConcept C118552586 @default.
• W2145411175 hasConcept C126322002 @default.
• W2145411175 hasConcept C141071460 @default.
• W2145411175 hasConcept C168563851 @default.
• W2145411175 hasConcept C17744445 @default.
• W2145411175 hasConcept C1862650 @default.
• W2145411175 hasConcept C197934379 @default.
• W2145411175 hasConcept C199539241 @default.
• W2145411175 hasConcept C27415008 @default.
• W2145411175 hasConcept C2776356578 @default.
• W2145411175 hasConcept C2776478404 @default.
• W2145411175 hasConcept C2778640784 @default.
• W2145411175 hasConcept C2779134260 @default.
• W2145411175 hasConcept C2779473830 @default.
• W2145411175 hasConcept C2781145037 @default.
• W2145411175 hasConcept C60465272 @default.
• W2145411175 hasConcept C71924100 @default.
• W2145411175 hasConcept C95190672 @default.
• W2145411175 hasConcept C99508421 @default.
• W2145411175 hasConceptScore W2145411175C118552586 @default.
• W2145411175 hasConceptScore W2145411175C126322002 @default.
• W2145411175 hasConceptScore W2145411175C141071460 @default.
• W2145411175 hasConceptScore W2145411175C168563851 @default.
• W2145411175 hasConceptScore W2145411175C17744445 @default.
• W2145411175 hasConceptScore W2145411175C1862650 @default.

• next